CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced the expansion of its industry-leading portfolio of capillary electrophoresis sequencing systems with the introduction of two new lines of genetic analyzers. The 3500 Series, for research use only, will be available worldwide. The 3500 Dx Series is intended for clinical use and will initially be launched in specific countries within the European Union. Both platforms will provide state-of-the-art advancements in CE sequencing systems, setting significant new standards for throughput, data quality and ease of use.
